Biomarkers in critical illness: have we made progress?

Area of Science:

• Biomarkers in translational medicine
• Clinical diagnostics and prognostics
• Critical care and postoperative patient management

Background:

• Biomarkers are crucial for early disease recognition, treatment, and follow-up across various pathologies.
• While biomarker sensitivity has significantly improved, specificity remains a challenge, particularly with overlapping conditions.
• Biomarker research offers substantial potential for diagnosing and predicting outcomes in postoperative and critically ill patients.

Approach:

• Assessing the role and limitations of biomarkers in complex clinical scenarios.
• Evaluating biomarker performance in patients with inflammation, infection, and organ dysfunction.
• Investigating the readiness of current biomarkers for routine clinical application.

Key Points:

• Improved biomarker sensitivity aids early detection but does not guarantee accurate diagnosis.
• Poor specificity is a major hurdle, especially when multiple biomarker-sensitive conditions coexist.
• Overlapping pathologies in critically ill patients complicate biomarker interpretation and utility.

Conclusions:

• Biomarkers hold significant promise for advancing diagnostic and prognostic capabilities.
• Current limitations in specificity prevent routine bedside use in critical care.
• Further research is needed to enhance biomarker accuracy and clinical applicability.